Racial and ethnic minorities are under-represented in many clinical trials because of less awareness of and access to clinical trials; a lack of direct recruitment due to provider bias; financial, transportation, and childcare burdens; language barriers; and misunderstandings about clinical research.
Why is diversity in clinical trials important? Minority populations are more likely to be diagnosed with certain cancers, stroke, diabetes, and are more likely to die prematurely than White Americans. Health disparities by race and ethnicity could increase if minority populations are not included in clinical trials. Additionally, racial and ethnic minorities may experience unanticipated side effects and lack of efficacy after drug approval if they aren’t included in clinical trials.
This webinar will address: